Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ZNTL

Zentalis Pharmaceuticals, Inc.

CIK 0001725160 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$4.70
↓ 0.16 (-3.29%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals, Options

Key stats

Market Cap
$334.58M
P/E Ratio
-2.70
EPS
-1.91
Dividend Yield
Not covered
52W Position
61%
Beta
2.14

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.83
P/S
Not covered
EV/Revenue
Not covered
ROE
-68.0%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 61%
$1.21$6.95

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$137.06M
Total Assets
$288.97M
Free Cash Flow
-$125.25M

Recent news